CANCER OF ESOPHAGUS: TEN YEARS EXPERIENCE AT CENAR, QUETTA
AbstractBackground: A retrospective study of 659 patients of Ca Esophagus was conducted from 1 January 1990 to 31s'December 1999 (10 years) at CENAR Quetta. The aim of this study was to highlight the incidence, early detection,management, and various other parameters of Ca Esophagus. Results: During this period, 5819 new eases of cancerwere registered. Cases of Ca Esophagus constituted 659 (11.32 %) in number. It was studied that this cancer was the3th most common cancer registered in both sexes at our centre. 65 new cases of Ca Esophagus were registered atCENAR Quetta per annum on an average. Males slightly dominated the females. Maximum number of cases 470(71.31 %). were reported between ages 4 1 - 6 0 years with a median age of 55 years. Maximum number of cases399 (60.57 %), involved lower 3' of Esophagus. Squamous cell carcinoma was the most common histopathology seenin 574 cases (87.10 %). These patients were mainly treated with radiation therapy, palliative, because by the time theyreported, they were found in stage 111 and beyond. Some patients were also treated with chemotherapy along withradiation, but the overall prognosis was poor. A few patients have also undergone palliative surgery; such as pullthrough or push through tubes prior to radiotherapy. Conclusions: Since the patients presented with late & advanceddisease, it is, therefore, recommended that all cases of dysphagia particularly from this region of the country shouldbe thoroughly investigated with the suspicion of Ca Esophagus. It is further suggested that general population beeducated about the potential risk factors like smoking, use of naswar, beetle nut chewing, and intake of very hot food& beverages
I Fink U. Stein 10, Wilke H, Roder JD. Siewert JR,
Multimodal treatment for squamous cell Esophageal cancer.
World J Surg 1995. 19: 198-204
Flood WA and Forastiere AA. Esophageal cancer. Current
Opinion in Oncology 1995. 7: 381-386.
Kelson DP, llson DH Chemotherapy and combined modality
therapy lor Esophageal cancer Chest 1995, 107 S224-S232
Blot WJ. Esophageal cancer trends and risk factors. Seminars
in Oncol 1994; 21:403-410.
Blot WJ. Dcvcsa SS. KneHer RW. Eraumeni JF jr. Rising
incidence of adenocarcinoma of the Esophagus and gastric
cardia, JAMA 1991;265:1287-1289.
Blot WJ, Li JY, Taylor PR ct al. Nutrition intervention trials
in Linxian, China: Supplementation with specific vitamin/
mineral combinations, cancer incidence, and disease-specific
mortality in the general population. J Natl Cancer Inst 1993;
Brown LM. Hoover RN, Greenberg RS. Schoenberg JB,
Schwartz AG. Swanson JM. Are racial differences in
squamous cell Esophageal cancer explained by alcohol and
tobacco use? J Natl Cancer Inst 1994; 86:1340-1345.
Brown LM. Swanson CA. Gridley G, Swanson GM.
Schoenberg JB, Greenberg RS et al. Adenocarcinoma of the
Esophagus: role of obesity and diet. J Natl Cancer Inst 1995.
Cheng KK, Day NE. Davies TW. Oesophageal cancer
mortality in Europe: paradoxical time trend in relation to
smoking and drinking. Br J Cancer 1992, 65: 613-617.
Day NE. Varghese C. Oesophageal cancer. Cancer Surv 1994:
Falk GW. Richter JE. Reflux disease and Barrett's Esophagus
Endoscopy 1996; 28:13-21.
Fink U. Stein HJ. Wilke H, Roder JD, Siewert JR. Multimodal
treatment for squamous cell Esophageal cancer World J Surg
; 19: 198-204.
Flood WA. Forestier AA Esophageal cancer. Current Opinion
in Oncology 1995,7: 381-386.
Froelicher P. Miller G, The European experience with
Esophageal cancer limited to the mucosa and submucosa.
Gastrointestinal Endoscopy 1986;32:88-90.
Gray JR. Coldman AJ. Mac Donald WC. Cigarette and alcohol
use in patients with adenocarcinoma of the gastric cardia or
lower Esophagus. Cancer 1992; 69: 2227-2231
Kelsen DP. llson DH. Chemotherapy and combined modality
therapy for Esophageal cancer. Chest 1995; 107: S224-S232.
17 Lambert R Endoscopic detection and treatment of early
Esophageal cancer: a critical analysis. Endoscopy 1995;27:12-
Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, Ershow AG et
al. Nutrition intervention trials in Linxian, China:
Multiple vitamin/mineral supplementation, cancer incidence
and disease-specific mortality among adults with Esophageal
dysplasia. J Natl Cancer Inst 1993; 85: 1492-1498
Light dale CJ. Diagnosis of esophagogastric tumors.
Endoscopy 1996; 28: 22-26
Macfarlane GJ, Plesko I, Kramarova E et al. Epidemiological
features of gastric and oesophageal cancer in Slovakia. Br J
Cancer 1994; 70: 177-9.
Moller FI. Boyle P, Maisonneuve P. La Vecchia C, Jensen OM
et al. Changing mortality from Esophageal cancer in males in
Denmark and other European countries in relation to changing
levels of alcohol consumption.
Cancer Causes Control 1990; 1:181-188.
Spechler S. Barrett's Esophagus Sem Oncol 1994; 21:
Akiyama H. Tsurumaru M. Udagawa H, Kajiyama Y.
Radical lymph node dissection for cancer of the thoracic
Esophagus, Ann Surg 1994; 220: 364-377